Company profile for Scilex Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We’re committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them most. With a passion for patients and a dedication to innovation, SCILEX is lighting the way forward in pain management. The mission of the Leadership Team is to bolster our proprietary pain management technology by employing years of expertise that comes with overseeing ...
We’re committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them most. With a passion for patients and a dedication to innovation, SCILEX is lighting the way forward in pain management. The mission of the Leadership Team is to bolster our proprietary pain management technology by employing years of expertise that comes with overseeing market access, commercialization, advocacy, and government affairs programs. These seasoned professionals bring SCILEX a type of leadership that is unmatched in the pharmaceutical industry

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
960 San Antonio Rd, Palo Alto, CA 94303
Telephone
Telephone
(650) 516-4310
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/26/3194964/0/en/Scilex-Holding-Company-Announces-Closing-of-Previously-Announced-Second-Tranche-Investment-in-Datavault-AI-Inc-Completing-Its-Two-Tranche-Equity-Financing-in-Datavault-AI-Inc.html

GLOBENEWSWIRE
26 Nov 2025

https://www.globenewswire.com/news-release/2025/11/25/3194673/0/en/Scilex-Holding-Company-Announces-Closing-of-Exercise-of-Warrants-for-20-3-Million-Gross-Proceeds.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/24/3193308/0/en/Scilex-Holding-Company-Announces-Exercise-of-Warrants-for-20-3-Million-Gross-Proceeds.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/21/3193009/0/en/Scilex-Holding-Company-Announces-Update-Regarding-Distribution-of-Dream-Bowl-2026-Meme-Coin-by-Datavault-AI-Inc.html

GLOBENEWSWIRE
21 Nov 2025

https://www.globenewswire.com/news-release/2025/11/11/3185524/0/en/Scilex-Holding-Company-Announces-that-the-Board-of-Directors-of-Datavault-AI-Inc-Has-Approved-the-Distribution-of-a-Dream-Bowl-2026-Meme-Coin-to-All-Eligible-Scilex-and-Datavault-A.html

GLOBENEWSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179474/0/en/Scilex-Holding-Company-Announces-the-Sponsorship-of-Dream-Bowl-2026-and-Set-a-Record-Date-of-November-14-2025-for-Its-Shareholders-to-Receive-Dream-Bowl-2026-Meme-Coin-Distributed-.html

GLOBENEWSWIRE
03 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty